Cite
Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells
MLA
Dandan Sheng, et al. “Development of a Novel Method for Rapid Cloning of ShRNA Vectors, Which Successfully Knocked down CD44 in Mesenchymal Triple-Negative Breast Cancer Cells.” Cancer Communications (London, England), vol. 38, no. 1, Apr. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c48c095c72e6239c18a68fd137bab4d0&authtype=sso&custid=ns315887.
APA
Dandan Sheng, Qiaodan Deng, Suling Liu, Lei Zhou, & Dong Wang. (2018). Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells. Cancer Communications (London, England), 38(1).
Chicago
Dandan Sheng, Qiaodan Deng, Suling Liu, Lei Zhou, and Dong Wang. 2018. “Development of a Novel Method for Rapid Cloning of ShRNA Vectors, Which Successfully Knocked down CD44 in Mesenchymal Triple-Negative Breast Cancer Cells.” Cancer Communications (London, England) 38 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c48c095c72e6239c18a68fd137bab4d0&authtype=sso&custid=ns315887.